Stratasys (SSYS) 6-K 13 Nov 19 2019 Q3 Condensed Consolidated Financial Statements Financial data

Document and Entity Information

Document and Entity Information	9 Months Ended
	Sep. 30, 2019
Document and Entity Information [Abstract]
Entity Registrant Name	STRATASYS LTD.
Entity Central Index Key	0001517396
Current Fiscal Year End Date	--12-31
Trading Symbol	SSYS
Document Type	6-K
Amendment Flag	false
Document Period End Date	Sep. 30, 2019
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2019

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Current assets
Cash and cash equivalents	$ 347,082	$ 393,167
Accounts receivable, net	133,743	138,146
Inventories	164,742	123,524
Prepaid expenses	7,646	6,398
Other current assets	29,765	22,936
Total current assets	682,978	684,171
Non-current assets
Property, plant and equipment, net	187,712	188,150
Goodwill	385,332	385,849
Other intangible assets, net	90,297	107,274
Operating lease right-of-use assets	21,757
Other non-current assets	22,977	22,810
Total non-current assets	708,075	704,083
Total assets	1,391,053	1,388,254
Current liabilities
Accounts payable	43,139	45,855
Current portion of long-term debt		5,143
Accrued expenses and other current liabilities	33,176	39,115
Accrued compensation and related benefits	35,413	31,703
Deferred revenues	53,214	53,965
Operating lease liabilities - short term	9,016
Total current liabilities	173,958	175,781
Non-current liabilities
Long-term debt		22,000
Deferred revenues - long-term	15,742	18,422
Operating lease liabilities - long term	13,303
Other non-current liabilities	32,580	29,084
Total non-current liabilities	61,625	69,506
Total liabilities	235,583	245,287
Contingencies (see note 11)
Redeemable non-controlling interests	700	852
Equity
Ordinary shares, NIS 0.01 nominal value, authorized 180,000 thousands shares; 54,428 thousands shares and 53,881 thousands shares issued and outstanding at September 30, 2019 and December 31, 2018, respectively	148	146
Additional paid-in capital	2,701,974	2,681,048
Accumulated other comprehensive loss	(7,967)	(7,753)
Accumulated deficit	(1,539,385)	(1,531,326)
Total equity	1,154,770	1,142,115
Total liabilities and equity	$ 1,391,053	$ 1,388,254

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - ₪ / shares shares in Thousands	Sep. 30, 2019	Dec. 31, 2018
Statement of Financial Position [Abstract]
Common stock, par value (in NIS per share)	₪ 0.01	₪ 0.01
Common stock, shares authorized	180,000	180,000
Common stock, shares issued	54,428	53,881
Common stock, shares outstanding	54,428	53,881

Consolidated Statements of Oper

Consolidated Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Net sales
Total net sales	$ 157,460	$ 162,049	$ 475,923	$ 486,118
Cost of sales
Total cost of sales	80,051	83,121	240,890	247,893
Gross profit	77,409	78,928	235,033	238,225
Operating expenses
Research and development, net	23,620	25,786	70,234	74,585
Selling, general and administrative	59,741	49,792	173,217	168,684
Total operating expenses	83,361	75,578	243,451	243,269
Operating income (loss)	(5,952)	3,350	(8,418)	(5,044)
Financial income (expense), net	289	(39)	2,796	(114)
Income (loss) before income taxes	(5,663)	3,311	(5,622)	(5,158)
Income tax expenses	586	304	3,084	1,110
Share in profit (losses) of associated companies	(733)	(3,752)	495	(11,185)
Net loss	(6,982)	(745)	(8,211)	(17,453)
Net loss attributable to non-controlling interests	(41)	(66)	(152)	(182)
Net loss attributable to Stratasys Ltd.	$ (6,941)	$ (679)	$ (8,059)	$ (17,271)
Net loss per ordinary share attributable to Stratasys Ltd. - basic and diluted	$ (0.13)	$ (0.01)	$ (0.15)	$ (0.34)
Weighted average ordinary shares outstanding. - basic and diluted	54,394	53,769	54,201	53,716
Comprehensive loss
Net loss	$ (6,982)	$ (745)	$ (8,211)	$ (17,453)
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	(954)	(234)	(1,398)	(1,445)
Unrealized gains (losses) on derivatives designated as cash flow hedges	34	522	1,184	(347)
Other comprehensive income (loss), net of tax	(920)	288	(214)	(1,792)
Comprehensive loss	(7,902)	(457)	(8,425)	(19,245)
Less: comprehensive loss attributable to non-controlling interests	(41)	(66)	(152)	(182)
Comprehensive loss attributable to Stratasys Ltd.	(7,861)	(391)	(8,273)	(19,063)
Products [Member]
Net sales
Total net sales	106,346	109,647	321,778	331,967
Cost of sales
Total cost of sales	44,341	48,640	135,605	147,120
Services [Member]
Net sales
Total net sales	51,114	52,402	154,145	154,151
Cost of sales
Total cost of sales	$ 35,710	$ 34,481	$ 105,285	$ 100,773

Consolidated Statements of Chan

Consolidated Statements of Changes in Equity - USD ($) shares in Thousands, $ in Thousands	Ordinary Shares [Member]		Additional Paid-In Capital [Member]	Accumulated deficit [Member]	Accumulated Other Comprehensive Loss [Member]	Equity attributable to Stratasys Ltd. [Member]	Non-controlling Interests [Member]	Total
Beginning Balance at Dec. 31, 2017	$ 145		$ 2,663,274	$ (1,523,906)	$ (7,023)	$ 1,132,490	$ 17	$ 1,132,507
Beginning Balance (in shares) at Dec. 31, 2017	53,631
Cumulative effect of changes in accounting principles				3,544		3,544		3,544
Issuance of shares in connection with stock-based compensation plans		[1]	334			334		334
Issuance of shares in connection with stock-based compensation plans (in shares)	79
Stock-based compensation			3,415			3,415		3,415
Comprehensive income (loss)				(13,041)	1,686	(11,355)	(34)	(11,389)
Ending Balance at Mar. 31, 2018	$ 145		2,667,023	(1,533,403)	(5,337)	1,128,428	(17)	1,128,411
Ending Balance (in shares) at Mar. 31, 2018	53,710
Issuance of shares in connection with stock-based compensation plans	$ 1		38			39		39
Issuance of shares in connection with stock-based compensation plans (in shares)	19
Stock-based compensation			4,278			4,278		4,278
Purchase of redeemable non-controlling interests			(935)			(935)		(935)
Comprehensive income (loss)				(3,551)	(3,766)	(7,317)	17	(7,300)
Ending Balance at Jun. 30, 2018	$ 146		2,670,404	(1,536,954)	(9,103)	1,124,493		1,124,493
Ending Balance (in shares) at Jun. 30, 2018	53,729
Issuance of shares in connection with stock-based compensation plans		[1]	1,344	0		1,344		1,344
Issuance of shares in connection with stock-based compensation plans (in shares)	81
Stock-based compensation			4,013			4,013		4,013
Purchase of redeemable non-controlling interests			1			1		1
Comprehensive income (loss)				(679)	288	(391)		(391)
Ending Balance at Sep. 30, 2018	$ 146		2,675,762	(1,537,633)	(8,815)	1,129,460		1,129,460
Ending Balance (in shares) at Sep. 30, 2018	53,810
Beginning Balance at Dec. 31, 2018	$ 146		2,681,048	(1,531,326)	(7,753)	1,142,115		1,142,115
Beginning Balance (in shares) at Dec. 31, 2018	53,881
Issuance of shares in connection with stock-based compensation plans		[1]	2,222			2,222		2,222
Issuance of shares in connection with stock-based compensation plans (in shares)	167
Stock-based compensation			4,229			4,229		4,229
Comprehensive income (loss)				(2,270)	568	(1,702)		(1,702)
Ending Balance at Mar. 31, 2019	$ 146		2,687,499	(1,533,596)	(7,185)	1,146,864		1,146,864
Ending Balance (in shares) at Mar. 31, 2019	54,048
Issuance of shares in connection with stock-based compensation plans	$ 1		2,030			2,031		2,031
Issuance of shares in connection with stock-based compensation plans (in shares)	296
Stock-based compensation			6,093			6,093		6,093
Comprehensive income (loss)				1,152	138	1,290		1,290
Ending Balance at Jun. 30, 2019	$ 147		2,695,622	(1,532,444)	(7,047)	1,156,278		1,156,278
Ending Balance (in shares) at Jun. 30, 2019	54,344
Issuance of shares in connection with stock-based compensation plans	$ 1		917			918		918
Issuance of shares in connection with stock-based compensation plans (in shares)	84
Stock-based compensation			5,435			5,435		5,435
Comprehensive income (loss)				(6,941)	(920)	(7,861)		(7,861)
Ending Balance at Sep. 30, 2019	$ 148		$ 2,701,974	$ (1,539,385)	$ (7,967)	$ 1,154,770		$ 1,154,770
Ending Balance (in shares) at Sep. 30, 2019	54,428
[1]	Represents an amount less than 0.5 thousand.

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Cash flows from operating activities
Net loss	$ (8,211)	$ (17,453)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	37,934	45,902
Stock-based compensation	15,757	11,706
Foreign currency transaction loss (gain)	777	3,450
Deferred income taxes	(1,667)	(3,733)
Share in (profits) losses of associated companies	(495)	11,185
Gain from sale of subsidiaries and unconsolidated entity	(3,578)	(7,932)
Other non-cash items, net	720	2,577
Change in cash attributable to changes in operating assets and liabilities:
Accounts receivable, net	2,827	1,681
Inventories	(44,925)	(7,723)
Net investment in sales-type leases	2,450	6,120
Other current assets and prepaid expenses	(6,922)	(2,980)
Other non-current assets	5,377	(1,075)
Accounts payable	(4,793)	(289)
Other current liabilities	(424)	3,330
Deferred revenues	(2,764)	2,504
Other non-current liabilities	172	(2,222)
Net cash provided by (used in) operating activities	(7,765)	45,048
Cash flows from investing activities
Purchase of property and equipment	(16,472)	(18,908)
Investment in unconsolidated entities	(4,500)	(13,015)
Purchase of intangible assets	(1,643)	(1,114)
Proceeds from sale of plant and property	129	4,105
Proceeds from sale of subsidiaries and unconsolidated entity	4,909	8,998
Other investing activities	(679)	(229)
Net cash used in investing activities	(18,256)	(20,163)
Cash flows from financing activities
Repayment of debt	(27,293)	(3,857)
Proceeds from exercise of stock options	5,169	2,379
Acquisition of redeemable non-controlling interests		(1,500)
Net cash used in financing activities	(22,124)	(2,978)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	1,602	(1,801)
Net change in cash, cash equivalents and restricted cash	(46,543)	20,106
Cash, cash equivalents and restricted cash, beginning of period	393,734	329,359
Cash, cash equivalents and restricted cash, end of period	347,191	349,465
Supplemental disclosures of cash flow information:
Transfer of fixed assets to inventory	201	380
Transfer of inventory to fixed assets	$ 2,304	$ 1,859

Business Description and Basis

Business Description and Basis of Presentation	9 Months Ended
	Sep. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business Description and Basis of Presentation	Note 1. Business Description and Basis of Presentation Stratasys Ltd. (collectively with its subsidiaries, the “Company”) is a global provider of applied additive technology solutions for a broad range of industries. The Company focuses on customers’ business requirements and seeks to create new value for its customers across their product lifecycle processes, from design prototypes to manufacturing tools and final production parts. The Company operates a 3D printing ecosystem of solutions and expertise, comprised of: 3D printers ranging from entry-level desktop 3D printers to systems for rapid prototyping (“RP”) and large production systems for direct digital manufacturing (“DDM”) based on precise fused deposition modeling (“FDM”) and PolyJet technologies; advanced materials for use with its 3D printers; software with voxel level control; application-based services; on-demand parts; and key partnerships. The condensed consolidated interim financial statements include the accounts of Stratasys Ltd. and its subsidiaries. All intercompany accounts and transactions, including profits from intercompany sales not yet realized outside the Company, have been eliminated in consolidation. The consolidated interim financial information herein is unaudited; however, such information reflects all adjustments (consisting of normal, recurring adjustments), which are, in the opinion of management, necessary for a fair statement of results for the interim period. The results of operations for the three and nine September

New Accounting Pronouncements

New Accounting Pronouncements	9 Months Ended
	Sep. 30, 2019
New Accounting Pronouncements
New Accounting Pronouncements	Note 2. New Accounting Pronouncements Accounting Pronouncements Adopted in the Current Period In July 2019, the Financial Accounting Standards Board (“FASB”) issued a new Accounting Standards Update (“ASU”) which aligns the disclosure and presentation requirements of a variety of codification topics with the SEC’s regulations. Company adopted this guidance upon its issuance, which has not had a material impact on its consolidated financial statements. In June 2018, the Financial Accounting Standards Board (“FASB”) issued a new Accounting Standards Update (“ASU”) which substantially aligns the measurement and classification guidance for share-based payments to non-employees with the guidance for share-based payments to employees. That ASU also clarifies that any share-based payment issued to a customer should be evaluated based upon the new revenue recognition standard. The new ASU required a modified retrospective transition approach. The Company adopted this guidance effective January 1, 2019, which has not had a material impact on its consolidated financial statements. In August 2017, the FASB issued an ASU which simplifies the designation and measurement requirements of hedge accounting in certain situations and allows companies to better align their hedge accounting with their risk management activities. The ASU also eases certain hedge effectiveness assessment requirements, expands the eligibility of hedging strategies that may qualify for hedge accounting and modifies certain presentation and disclosure requirements. The Company adopted this guidance effective January 1, 2019, which has not had a material impact on its consolidated financial statements. In February 2016, the FASB issued a new ASU which amended its lease accounting guidance. Under the new lease accounting guidance, lessees are required to recognize a right-of-use asset and a lease liability for all leases, including leases classified as operating leases. The lease liability and the right-of-use asset are measured based on the present value of the lease payments. In addition, disclosures of qualitative and quantitative information about leasing arrangements are required. The new lease accounting guidance also contains amended guidance regarding the identification of embedded leases in service contracts and the identification of lease and non-lease components of an arrangement. The Company adopted the new lease accounting guidance on January 1, 2019, using a modified retrospective transition approach, with certain practical expedients, and as a result did not adjust prior periods. Following the adoption, the Company recognized right-of-use assets of $27.4 million and lease liabilities of $27.9 million for its operating leases. The Company does not have material finance leases. The new lease accounting guidance had no material impact on the Company's Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) and no material impact on the Condensed Consolidated Statements of Cash Flows. The Company determines whether an arrangement contains a lease at the inception of a contract. If an arrangement is a lease, the Company determines whether it is an operating lease or a finance lease. The Company's lease terms include all non-cancelable periods and may include options to extend the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases is recognized on a straight-line basis over the lease term. The Company elected the short-term lease recognition exemption for all leases with terms shorter than twelve months. The right-of-use assets represent the Company's right to control the use of an underlying asset for the lease term. The lease liabilities represent the present value of the Company's future lease payments over the expected lease term, which is determined using the Company's incremental borrowing rate at the lease commencement date. This rate is determined considering factors such as the lease term, credit standing and the economic environment of the location of the lease. The Company's leases primarily relate to buildings for the Company’s administrative, research and development, sales and marketing, and manufacturing activities, as well as vehicles leases. As of September 30, 2019, the weighted average remaining lease term for the Company’s leases was 3.1 years, and weighted-average discount rate was 4.7%. Recently Issued Accounting Pronouncements Not Yet Adopted In August 2018, the FASB issued an ASU that clarifies the accounting for implementation costs in cloud computing arrangements. This ASU requires the implementation costs incurred by customers in cloud computing arrangements to be deferred and recognized over the term of the arrangement, if those costs would be capitalized by the customers in a software licensing arrangement. The guidance will be effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019, with early adoption permitted. The Company is currently evaluating the impact of the adoption of the new guidance on its consolidated financial statements. In June 2016, the FASB issued an ASU that supersedes the existing impairment model for most financial assets to a current expected credit loss model. The new guidance requires an entity to recognize an impairment allowance equal to its current estimate of all contractual cash flows the entity does not expect to collect. The ASU also requires that credit losses relating to available-for-sale debt securities will be recorded through an allowance for credit losses. The new guidance is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of the new guidance on its consolidated financial statements.

Revenues

Revenues	9 Months Ended
	Sep. 30, 2019
Revenue Recognition [Abstract]
Revenues	Note 3. Revenues Disaggregation of Revenues The following table presents the Company’s revenues disaggregated by geographical region (based on the Company's customers' locations) and revenue type for the three and nine months ended September 30, 2019 and 2018: Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 (U.S. $ in thousands) (U.S. $ in thousands) Americas Products $ 67,088 $ 64,257 $ 192,279 $ 181,695 Service 39,816 40,770 119,149 118,036 Total Americas 106,904 105,027 311,428 299,731 EMEA Products 22,710 25,880 74,119 87,808 Service 6,223 6,556 19,747 20,826 Total EMEA 28,933 32,436 93,866 108,634 Asia Pacific Products 16,548 19,511 55,380 62,464 Service 5,075 5,075 15,249 15,289 Total Asia Pacific 21,623 24,586 70,629 77,753 Total Revenues $ 157,460 $ 162,049 $ 475,923 $ 486,118 The following table presents the Company’s revenues disaggregated based on the timing of revenue recognized for the three and nine months ended September 30, 2019 and 2018: Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 (U.S. $ in thousands) (U.S. $ in thousands) Revenues recognized in point in time from: Products $ 106,346 $ 109,647 $ 321,778 $ 331,967 Services 11,157 10,743 32,531 31,880 Total revenues recognized in point in time 117,503 120,390 354,309 363,847 Revenues recognized over time from: Services 39,957 41,659 121,614 122,271 Total revenues recognized over time 39,957 41,659 121,614 122,271 Total Revenues $ 157,460 $ 162,049 $ 475,923 $ 486,118 Contract Assets and Contract Liabilities Contract assets are recorded when the Company's right to consideration is conditional on constraints other than the passage of time. The Company had no material contract assets as of September 30, 2019. Contract liabilities include advance payments and billings in excess of revenue recognized, which are primarily related to advanced billings for service type warranty. Contract liabilities are presented under deferred revenues. The Company's deferred revenues as of September 30, 2019 and December 31, 2018 were as follows: September 30, December 31, 2019 2018 U.S. $ in thousands Deferred revenue* 68,956 *Includes $15.7 million and $18.4 million under long-term Revenue recognized in 2019 that was included in deferred revenue balance as of January 1, 2019 was $10.9 million and $42.8 million for the three and nine months ended September 30, 2019, respectively. Remaining Performance Obligations Remaining Performance Obligations ("RPO") represents contracted revenue that has not yet been recognized, which includes deferred revenue and amounts that will be invoiced and recognized as revenue in future periods. As of September 30, 2019, the total RPO amounted to 89.4 million. The Company expects to recognize $70.1 million of this RPO during the next 12 months, $14.0 million over the subsequent 12 months and the remaining $5.3 million Incremental Costs of Obtaining a Contract Sales commissions earned mainly by the Company’s sales agents are considered incremental costs of obtaining a contract with a customer, as the Company expects the benefit of those commissions to be longer than one year. The majority of the sales commissions are not subject to capitalization, as the commission expense is recognized as the related revenue is recognized. Sales commissions for initial contracts related to the service type warranty are deferred and then amortized on a straight-line basis over the expected customer relationship period if the Company expects to recover those costs. Amortization expense is included in selling, general and administrative expenses in the consolidated statements of operations. As of September 30, 2019 and December 31, 2018, the deferred commission amounted to $3.7 million and $3.1 million respectively.

Inventories

Inventories	9 Months Ended
	Sep. 30, 2019
Inventory Disclosure [Abstract]
Inventories	Note 4. Inventories Inventories consisted of the following: September 30, December 31, 2019 2018 U.S. $ in thousands Finished goods $ 87,046 $ 61,391 Work-in-process 3,388 2,616 Raw materials 74,308 59,517 164,742 123,524

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	9 Months Ended
	Sep. 30, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets	Note 5. Goodwill and Other Intangible Assets Goodwill Changes in the carrying amount of the Company’s goodwill for the nine-months ended September 30, 2019 were as follows: U.S. $ in thousands Goodwill as of January 1, 2019 $ 385,849 Foreign currency translation adjustments (517 ) Goodwill as of September 30, 2019 $ 385,332 During the fourth quarter of 2018, the Company performed a quantitative assessment for goodwill impairment for its Stratasys-Objet reporting unit. Following its quantitative assessment, the Company concluded that the fair value of its Stratasys-Objet reporting unit exceeded its carrying amount by approximately 8%, with a carrying amount of goodwill assigned to this reporting unit in an amount of $386 million. When evaluating the fair value of its Stratasys-Objet reporting unit the Company used a discounted cash flow model which utilized Level 3 measures that represent unobservable inputs into the valuation method. Key assumptions used to determine the estimated fair value include: (a) expected cash flows for five years following the assessment date which were based on, among other factors, expected revenue growth, costs to produce, operating profit margins and estimated capital needs; (b) an estimated terminal value that utilized a terminal year growth rate of 3.1% that was determined based on the growth prospects of the reporting unit; and (c) a discount rate of 14.0% based on management’s best estimate of the after-tax weighted average cost of capital. If any of these were to vary materially from the Company's estimates, the Company could face impairment of goodwill allocated to this reporting unit in the future. Actual results may differ from those assumed in the Company's valuation method. It is reasonably possible that the Company's assumptions described above could change in future periods. If any of these were to vary materially from the Company's plans, it may record impairment of goodwill allocated to this reporting unit in the future. A hypothetical decrease in the growth rate of 1% or an increase of 1% to the discount rate would have reduced the fair value of Stratasys-Objet reporting unit by approximately $48 million and $80 million, respectively. Based on the Company’s assessment as of December 31, 2018, no goodwill was determined to be impaired. During the third quarter of 2019 the Company reaffirmed that no significant events or circumstances occurred that contradict the assumptions and data used in the annual impairment test performed in the fourth quarter of 2018. Determining the fair value of the Stratasys-Objet reporting unit requires significant judgment, including judgments about the appropriate discount rates, terminal growth rates, weighted average costs of capital and the amount and timing of projected future cash flows. The Company will continue to monitor the fair value of its Stratasys-Objet reporting unit to determine whether events and changes in circumstances such as a deterioration in the business climate or operating results, significant decline in the Company's share price, changes in management’s business strategy or downward changes of the Company's cash flows projections, warrant further interim impairment testing. Other Intangible Assets Other intangible assets consisted of the following: September 30, 2019 December 31, 2018 Carrying Amount, Net Carrying Amount, Net Net of Accumulated Book Net of Accumulated Book Impairment Amortization Value Impairment Amortization Value U.S. $ in thousands Developed technology $ 299,100 $ (248,197 ) $ 50,903 $ 299,100 $ (236,375 ) $ 62,725 Patents 11,739 (6,510 ) 5,229 10,127 (5,752 ) 4,375 Trademarks and trade names 26,235 (19,933 ) 6,302 26,212 (19,067 ) 7,145 Customer relationships 102,837 (75,116 ) 27,721 102,984 (70,353 ) 32,631 Capitalized software development costs 19,541 (19,399 ) 142 19,540 (19,142 ) 398 $ 459,452 $ (369,155 ) $ 90,297 $ 457,963 $ (350,689 ) $ 107,274 Amortization expense relating to intangible assets for the three-month periods ended September 30, 2019 and 2018 was approximately $6.5 million and $8.0 million, respectively. Amortization expense relating to intangible assets for the nine-month periods ended September 30, 2019 and 2018 was approximately $18.6 million and $24.2 million, respectively. As of September 30, 2019, the estimated amortization expense relating to intangible assets for each of the following periods was as follows: Estimated amortization expense (U.S. $ in thousands) Remaining 3 months of 2019 $ 6,275 2020 24,278 2021 24,118 2022 24,022 Thereafter 11,604 Total 90,297

Loss Per Share

Loss Per Share	9 Months Ended
	Sep. 30, 2019
Earnings Per Share [Abstract]
Loss Per Share	Note 6. Loss Per Share The following table presents the numerator and denominator of the basic and diluted net loss per share computations for the three and nine months ended September 30, 2019 and 2018: Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 In thousands, except per share amounts In thousands, except per share amounts Numerator: Net loss attributable to Stratasys Ltd. $ (6,941 ) $ (679 ) $ (8,059 ) $ (17,271 ) Adjustment of redeemable non-controlling interest to redemption amount - - - (935 ) Net loss attributable to Stratasys Ltd. for basic and diluted loss per share (6,941 ) (679 ) (8,059 ) (18,206 ) Denominator: Weighted average shares - denominator for basic and diluted net loss per share 54,394 53,769 54,201 53,716 Net loss per share attributable to Stratasys Ltd. Basic $ (0.13 ) $ (0.01 ) $ (0.15 ) $ (0.34 ) Diluted $ (0.13 ) $ (0.01 ) $ (0.15 ) $ (0.34 ) The computation of diluted net loss per share excluded share awards of 4.5 million shares and 4.2 million shares for the three and nine months ended September 30, 2019 and 2018, respectively, because their inclusion would have had an anti-dilutive effect on the diluted net loss per share

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2019
Income Tax Disclosure [Abstract]
Income Taxes	Note 7. Income Taxes The Company had a negative effective tax rate of 10.3% for the three-month period period period period

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2019
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 8. Fair Value Measurements Financial instruments measured at fair value The following table summarizes September 30, 2019 December 31, 2018 (U.S. $ in thousands) Assets: Foreign exchange forward contracts not designated as hedging instruments $ 857 $ 374 Foreign exchange forward contracts designated as hedging instruments 556 - Liabilities: Foreign exchange forward contracts not designated as hedging instruments (184 ) (196 ) Foreign exchange forward contracts designated as hedging instruments - (628 ) $ 1,229 $ (450 ) The Company’s foreign exchange forward contracts are classified as Level 2, as they are not actively traded and are valued using pricing models that use observable market inputs, including interest rate curves and both forward and spot prices for currencies (Level 2 inputs). Other financial instruments consist mainly of cash and cash equivalents, current and non-current receivables, net investment in sales-type leases, bank loan, accounts payable and other current liabilities. The fair value of these financial instruments approximates their carrying values.

Derivative instruments and hedg

Derivative instruments and hedging activities	9 Months Ended
	Sep. 30, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative instruments and hedging activities	Note 9. Derivative instruments and hedging activities Since the Company conducts its operations globally, it is exposed to global market risks and to the risk that its earnings, cash flows and equity could be adversely impacted by fluctuations in foreign currency exchange rates. The Company enters into transactions involving foreign currency exchange derivative financial instruments. The Company manages its foreign currency exposures on a consolidated basis, which allows the Company to net exposures and take advantage of any natural hedging. The transactions are designed to manage the Company’s net exposure to foreign currency exchange rates and to reduce the volatility of earnings and cash flows associated with changes in foreign currency exchange rates. The Company does not enter into derivative transactions for trading purposes. The Company is primarily exposed to foreign exchange risk with respect to recognized assets and liabilities and forecasted transactions denominated in the New Israeli Shekel (“NIS”), Euro, Korean Won, Chinese Yuan and the Japanese Yen. The gains and losses on the hedging instruments partially offset losses and gains on the hedged items. Financial markets and currency volatility may limit the Company’s ability to hedge these exposures. The following table summarizes the consolidated balance sheets classification and fair values of the Company’s derivative instruments: Fair Value Notional Amount September 30, December 31, September 30, December 31, Balance sheet location 2019 2018 2019 2018 U.S. $ in thousands Assets derivatives -Foreign exchange contracts, not designated as hedging instruments Other current assets $ 857 $ 374 $ 66,206 $ 34,695 Assets derivatives -Foreign exchange contracts, designated as cash flow hedge Other current assets 556 - 16,955 - Liability derivatives -Foreign exchange contracts, not designated as hedging instruments Accrued expenses and other current liabilities (184 ) (196 ) 21,907 54,425 Liability derivatives -Foreign exchange contracts, designated as hedging instruments Accrued expenses and other current liabilities - (628 ) - 41,303 $ 1,229 $ (450 ) $ 105,068 $ 130,423 As of September 30, 2019, the notional amounts of the Company’s outstanding exchange forward contracts, not designated as hedging instruments, were $88.1 million, and were used to reduce foreign currency exposures. With respect to such derivatives, gains of $3.2 million and $0.6 million and $1.5 million September As of September 30, 2019, the Company had in effect foreign exchange forward contracts, designated as cash flow hedge for accounting purposes, for the conversion of $17.0 million into NIS. The Company uses short-term cash flow hedge contracts to reduce its exposure to variability in expected future cash flows resulting mainly from payroll costs denominated in NIS. The changes in fair value of those contracts are included in the Company’s accumulated other comprehensive loss. These contracts mature through June 2020.

Equity

Equity	9 Months Ended
	Sep. 30, 2019
Equity [Abstract]
Equity	Note 10. Equity a. Stock-based compensation plans Stock-based compensation expenses for equity-classified stock options, restricted share units (“RSUs”) and performance stock units ("PSUs") were allocated as follows: Three Months Ended Nine Months Ended September 30, September 30, 2019 2018 2019 2018 U.S $ in thousands U.S $ in thousands Cost of sales $ 475 $ 351 $ 1,370 $ 1,180 Research and development, net 1,494 928 3,764 2,608 Selling, general and administrative 3,466 2,734 10,623 7,918 Total stock-based compensation expenses $ 5,435 $ 4,013 $ 15,757 $ 11,706 A summary of the Company’s stock option activity for the nine months ended September 30, 2019 is as follows: Weighted Average Number of Options Exercise Price Options outstanding as of January 1, 2019 2,551,743 $ 30.82 Exercised (242,317 ) 21.34 Forfeited (218,568 ) 27.40 Options outstanding as of September 30, 2019 2,090,858 $ 32.28 Options exercisable as of September 30, 2019 1,600,304 $ 35.90 During the nine-month periods ended September 30, 2019 and 2018, the Company issued 242,317 shares and 87,158 shares, respectively, upon the exercise of stock options. This resulted in an increase in equity of $5.2 million and $1.7 million for the nine-month periods ended September 30, 2019 and 2018, respectively. As of September 30, 2019, the unrecognized compensation cost of $5.1 million related to all unvested, equity-classified stock options is expected to be recognized as an expense over a weighted-average period of 1.4 years. A summary of the Company’s RSUs and PSUs activity for the nine months ended September 30, 2019 is as follows: Weighted Average Nu mber of RSUs and PS Us Grant Date Fair Value Unvested as of January 1, 2019 1,422,887 $ 20.17 Granted 1,564,182 26.61 Vested (304,408 ) 20.47 Forfeited (251,574 ) 22.19 Unvested as of September 30, 2019 2,431,087 $ 24.07 The fair value of RSUs and PSUs is determined based on the quoted price of the Company’s ordinary shares on the date of the grant. As of September 30, 2019, the unrecognized compensation cost of $45.1 million related to all unvested, equity-classified RSUs and PSUs is expected to be recognized as expense over a weighted-average period of 2.9 years. b. Accumulated other comprehensive loss The following tables present the changes in the components of accumulated other comprehensive income (loss), net of taxes, for the nine months ended September 30, 2019 and 2018, respectively: Nine months ended September 30, 2019 Net unrealized gain Foreign currency (loss) on cash flow translation hedges adjustments Total U.S. $ in thousands Balance as of January 1, 2019 $ (627 ) $ (7,126 ) $ (7,753 ) Other comprehensive income (loss) before reclassifications 1,689 (1,398 ) 291 Amounts reclassified from accumulated other comprehensive loss (505 ) - (505 ) Other comprehensive income (loss) 1,184 (1,398 ) (214 ) Balance as of September 30, 2019 $ 557 $ (8,524 ) $ (7,967 ) Nine months ended September 30, 2018 Net unrealized gain Foreign currency (loss) on cash flow translation hedges adjustments Total U.S. $ in thousands Balance as of January 1, 2018 $ 330 $ (7,353 ) $ (7,023 ) Other comprehensive income (loss) before reclassifications (733 ) (1,540 ) (2,273 ) Amounts reclassified from accumulated other comprehensive loss 386 95 481 Other comprehensive loss (347 ) (1,445 ) (1,792 ) Balance as of September 30, 2018 $ (17 ) $ (8,798 ) $ (8,815 )

Contingencies

Contingencies	9 Months Ended
	Sep. 30, 2019
Commitments and Contingencies Disclosure [Abstract]
Contingencies	Note 11. Contingencies Patent Law-Based Claim On November 23, 2017, a former employee, whose employment had been terminated by the Company in 2008 and who had previously unsuccessfully filed a suit against the Company, brought an additional proceeding against the Company under Section 134 of the Israeli Patent Law seeking compensation and royalties for service inventions he invented while he served as an employee of the Company. In this new proceeding, the former employee claims to be entitled to receive royalties in an amount equal to: (a) 20% of the benefits, revenues and /or savings generated by the Company in the past and in the future, including the rise in the value of the Company, as determined in the merger with Stratasys Inc., which took place in December 2012; (b) 20% of the gross profit generated by the Company in the past and 9% of the gross profit produced and that will be produced by the Company; (c) 20% of the gross profit generated by the Company in the past and the relative share of the former Objet entity of the Company in the total gross profit produced and that will be produced by the Company; or (d) 20% of the value of the service inventions at issue. The former employee further sought an order of accounts. The Company rejects the claims that serve as a basis for the proceeding and is defending against them vigorously. While the Company does not believe that the reasonably possible losses from this proceeding will be material to the Company's financial statements, those losses (if any) cannot be estimated at the current time. The Company is a party to various other legal proceedings, the outcome of which, in the opinion of management, will not have a significant adverse effect on the financial position, profitability or cash flows

Revenues (Tables)

Revenues (Tables)	9 Months Ended
	Sep. 30, 2019
Revenue Recognition [Abstract]
Schedule of Disaggregation of Revenues	The following table presents the Company’s revenues disaggregated by geographical region (based on the Company's customers' locations) and revenue type for the three and nine months ended September 30, 2019 and 2018: Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 (U.S. $ in thousands) (U.S. $ in thousands) Americas Products $ 67,088 $ 64,257 $ 192,279 $ 181,695 Service 39,816 40,770 119,149 118,036 Total Americas 106,904 105,027 311,428 299,731 EMEA Products 22,710 25,880 74,119 87,808 Service 6,223 6,556 19,747 20,826 Total EMEA 28,933 32,436 93,866 108,634 Asia Pacific Products 16,548 19,511 55,380 62,464 Service 5,075 5,075 15,249 15,289 Total Asia Pacific 21,623 24,586 70,629 77,753 Total Revenues $ 157,460 $ 162,049 $ 475,923 $ 486,118
Schedule of Disaggregation of Revenues Based on Time	The following table presents the Company’s revenues disaggregated based on the timing of revenue recognized for the three and nine months ended September 30, 2019 and 2018: Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 (U.S. $ in thousands) (U.S. $ in thousands) Revenues recognized in point in time from: Products $ 106,346 $ 109,647 $ 321,778 $ 331,967 Services 11,157 10,743 32,531 31,880 Total revenues recognized in point in time 117,503 120,390 354,309 363,847 Revenues recognized over time from: Services 39,957 41,659 121,614 122,271 Total revenues recognized over time 39,957 41,659 121,614 122,271 Total Revenues $ 157,460 $ 162,049 $ 475,923 $ 486,118
Schedule of Changes in Deferred Revenue	The Company's deferred revenues as of September 30, 2019 and December 31, 2018 were as follows: September 30, December 31, 2019 2018 U.S. $ in thousands Deferred revenue* 68,956 *Includes $15.7 million and $18.4 million under long term deferred revenue in the Company's consolidated balance sheets as of September 30, 2019 and December 31, 2018, respectively.

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Sep. 30, 2019
Inventory Disclosure [Abstract]
Schedule of Inventories	Inventories consisted of the following: September 30, December 31, 2019 2018 U.S. $ in thousands Finished goods $ 87,046 $ 61,391 Work-in-process 3,388 2,616 Raw materials 74,308 59,517 164,742 123,524

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Changes in the Carrying Amount of Goodwill	Changes in the carrying amount of the Company’s goodwill for the nine-months ended September 30, 2019 were as follows: U.S. $ in thousands Goodwill as of January 1, 2019 $ 385,849 Foreign currency translation adjustments (517 ) Goodwill as of September 30, 2019 $ 385,332
Schedule of Other Intangible Assets	Other intangible assets consisted of the following: September 30, 2019 December 31, 2018 Carrying Amount, Net Carrying Amount, Net Net of Accumulated Book Net of Accumulated Book Impairment Amortization Value Impairment Amortization Value U.S. $ in thousands Developed technology $ 299,100 $ (248,197 ) $ 50,903 $ 299,100 $ (236,375 ) $ 62,725 Patents 11,739 (6,510 ) 5,229 10,127 (5,752 ) 4,375 Trademarks and trade names 26,235 (19,933 ) 6,302 26,212 (19,067 ) 7,145 Customer relationships 102,837 (75,116 ) 27,721 102,984 (70,353 ) 32,631 Capitalized software development costs 19,541 (19,399 ) 142 19,540 (19,142 ) 398 $ 459,452 $ (369,155 ) $ 90,297 $ 457,963 $ (350,689 ) $ 107,274
Schedule of Estimated Amortization Expense Relating to Intangible Assets	As of September 30, 2019, the estimated amortization expense relating to intangible assets for each of the following periods was as follows: Estimated amortization expense (U.S. $ in thousands) Remaining 3 months of 2019 $ 6,275 2020 24,278 2021 24,118 2022 24,022 Thereafter 11,604 Total 90,297

Loss Per Share (Tables)

Loss Per Share (Tables)	9 Months Ended
	Sep. 30, 2019
Earnings Per Share [Abstract]
Schedule of Basic and Diluted Loss Per Share	The following table presents the numerator and denominator of the basic and diluted net loss per share computations for the three and nine months ended September 30, 2019 and 2018: Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 In thousands, except per share amounts In thousands, except per share amounts Numerator: Net loss attributable to Stratasys Ltd. $ (6,941 ) $ (679 ) $ (8,059 ) $ (17,271 ) Adjustment of redeemable non-controlling interest to redemption amount - - - (935 ) Net loss attributable to Stratasys Ltd. for basic and diluted loss per share (6,941 ) (679 ) (8,059 ) (18,206 ) Denominator: Weighted average shares - denominator for basic and diluted net loss per share 54,394 53,769 54,201 53,716 Net loss per share attributable to Stratasys Ltd. Basic $ (0.13 ) $ (0.01 ) $ (0.15 ) $ (0.34 ) Diluted $ (0.13 ) $ (0.01 ) $ (0.15 ) $ (0.34 )

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2019
Fair Value Disclosures [Abstract]
Schedule of Assets and Liabilities Carried at Fair Value on a Recurring Basis	The following table summarizes September 30, 2019 December 31, 2018 (U.S. $ in thousands) Assets: Foreign exchange forward contracts not designated as hedging instruments $ 857 $ 374 Foreign exchange forward contracts designated as hedging instruments 556 - Liabilities: Foreign exchange forward contracts not designated as hedging instruments (184 ) (196 ) Foreign exchange forward contracts designated as hedging instruments - (628 ) $ 1,229 $ (450 )

Derivative instruments and he_2

Derivative instruments and hedging activities (Tables)	9 Months Ended
	Sep. 30, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of balance sheet classification and fair values of derivative instruments	The following table summarizes the consolidated balance sheets classification and fair values of the Company’s derivative instruments: Fair Value Notional Amount September 30, December 31, September 30, December 31, Balance sheet location 2019 2018 2019 2018 U.S. $ in thousands Assets derivatives -Foreign exchange contracts, not designated as hedging instruments Other current assets $ 857 $ 374 $ 66,206 $ 34,695 Assets derivatives -Foreign exchange contracts, designated as cash flow hedge Other current assets 556 - 16,955 - Liability derivatives -Foreign exchange contracts, not designated as hedging instruments Accrued expenses and other current liabilities (184 ) (196 ) 21,907 54,425 Liability derivatives -Foreign exchange contracts, designated as hedging instruments Accrued expenses and other current liabilities - (628 ) - 41,303 $ 1,229 $ (450 ) $ 105,068 $ 130,423

Equity (Tables)

Equity (Tables)	9 Months Ended
	Sep. 30, 2019
Equity [Abstract]
Schedule of Share-based Compensation Expense	Stock-based compensation expenses for equity-classified stock options, restricted share units (“RSUs”) and performance stock units ("PSUs") were allocated as follows: Three Months Ended Nine Months Ended September 30, September 30, 2019 2018 2019 2018 U.S $ in thousands U.S $ in thousands Cost of sales $ 475 $ 351 $ 1,370 $ 1,180 Research and development, net 1,494 928 3,764 2,608 Selling, general and administrative 3,466 2,734 10,623 7,918 Total stock-based compensation expenses $ 5,435 $ 4,013 $ 15,757 $ 11,706
Summary of Stock Options Activity	A summary of the Company’s stock option activity for the nine months ended September 30, 2019 is as follows: Weighted Average Number of Options Exercise Price Options outstanding as of January 1, 2019 2,551,743 $ 30.82 Exercised (242,317 ) 21.34 Forfeited (218,568 ) 27.40 Options outstanding as of September 30, 2019 2,090,858 $ 32.28 Options exercisable as of September 30, 2019 1,600,304 $ 35.90
Summary of RSUs and PSUs activity	A summary of the Company’s RSUs and PSUs activity for the nine months ended September 30, 2019 is as follows: Weighted Average Nu mber of RSUs and PS Us Grant Date Fair Value Unvested as of January 1, 2019 1,422,887 $ 20.17 Granted 1,564,182 26.61 Vested (304,408 ) 20.47 Forfeited (251,574 ) 22.19 Unvested as of September 30, 2019 2,431,087 $ 24.07
Schedule of Accumulated other comprehensive income (loss)	The following tables present the changes in the components of accumulated other comprehensive income (loss), net of taxes, for the nine months ended September 30, 2019 and 2018, respectively: Nine months ended September 30, 2019 Net unrealized gain Foreign currency (loss) on cash flow translation hedges adjustments Total U.S. $ in thousands Balance as of January 1, 2019 $ (627 ) $ (7,126 ) $ (7,753 ) Other comprehensive income (loss) before reclassifications 1,689 (1,398 ) 291 Amounts reclassified from accumulated other comprehensive loss (505 ) - (505 ) Other comprehensive income (loss) 1,184 (1,398 ) (214 ) Balance as of September 30, 2019 $ 557 $ (8,524 ) $ (7,967 ) Nine months ended September 30, 2018 Net unrealized gain Foreign currency (loss) on cash flow translation hedges adjustments Total U.S. $ in thousands Balance as of January 1, 2018 $ 330 $ (7,353 ) $ (7,023 ) Other comprehensive income (loss) before reclassifications (733 ) (1,540 ) (2,273 ) Amounts reclassified from accumulated other comprehensive loss 386 95 481 Other comprehensive loss (347 ) (1,445 ) (1,792 ) Balance as of September 30, 2018 $ (17 ) $ (8,798 ) $ (8,815 )

New Accounting Pronouncements (

New Accounting Pronouncements (Details) $ in Millions	9 Months Ended
	Sep. 30, 2019USD ($)
New Accounting Pronouncements
Right-of-use assets	$ 27.4
Lease liabilities	$ 27.9
Weighted average remaining lease term	3 years 1 month 6 days
Weighted-average discount rate	4.70%

Revenues (Narrative) (Details)

Revenues (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2019	Dec. 31, 2018
Revenue Recognition [Abstract]
Revenue recognized	$ 10,900	$ 42,800
Deferred revenue noncurrent portion	15,742	15,742	$ 18,422
Remaining performance obligations	89,400	89,400
Expected remaining performance obligations recognized during next 12 months	70,100	70,100
Expected remaining performance obligations recognized subsequent to next 12 months	14,000	14,000
Expected remaining performance obligations recognized remainder thereafter	5,300	5,300
Deferred sales commissions	$ 3,700	$ 3,700	$ 3,100

Revenues (Schedule of Disaggreg

Revenues (Schedule of Disaggregation of Revenues) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Disaggregation of Revenue [Line Items]
Total Revenues	$ 157,460	$ 162,049	$ 475,923	$ 486,118
Products [Member]
Disaggregation of Revenue [Line Items]
Total Revenues	106,346	109,647	321,778	331,967
Services [Member]
Disaggregation of Revenue [Line Items]
Total Revenues	51,114	52,402	154,145	154,151
Americas [Member]
Disaggregation of Revenue [Line Items]
Total Revenues	106,904	105,027	311,428	299,731
Americas [Member] | Products [Member]
Disaggregation of Revenue [Line Items]
Total Revenues	67,088	64,257	192,279	181,695
Americas [Member] | Services [Member]
Disaggregation of Revenue [Line Items]
Total Revenues	39,816	40,770	119,149	118,036
EMEA [Member]
Disaggregation of Revenue [Line Items]
Total Revenues	28,933	32,436	93,866	108,634
EMEA [Member] | Products [Member]
Disaggregation of Revenue [Line Items]
Total Revenues	22,710	25,880	74,119	87,808
EMEA [Member] | Services [Member]
Disaggregation of Revenue [Line Items]
Total Revenues	6,223	6,556	19,747	20,826
Asia Pacific [Member]
Disaggregation of Revenue [Line Items]
Total Revenues	21,623	24,586	70,629	77,753
Asia Pacific [Member] | Products [Member]
Disaggregation of Revenue [Line Items]
Total Revenues	16,548	19,511	55,380	62,464
Asia Pacific [Member] | Services [Member]
Disaggregation of Revenue [Line Items]
Total Revenues	$ 5,075	$ 5,075	$ 15,249	$ 15,289

Revenues (Schedule of Disaggr_2

Revenues (Schedule of Disaggregation of Revenues Based on Time) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Disaggregation of Revenue [Line Items]
Total Revenues	$ 157,460	$ 162,049	$ 475,923	$ 486,118
Revenues recognized in point in time [Member]
Disaggregation of Revenue [Line Items]
Total Revenues	117,503	120,390	354,309	363,847
Revenues recognized over time [Member]
Disaggregation of Revenue [Line Items]
Total Revenues	39,957	41,659	121,614	122,271
Products [Member]
Disaggregation of Revenue [Line Items]
Total Revenues	106,346	109,647	321,778	331,967
Products [Member] | Revenues recognized in point in time [Member]
Disaggregation of Revenue [Line Items]
Total Revenues	106,346	109,647	321,778	331,967
Services [Member]
Disaggregation of Revenue [Line Items]
Total Revenues	51,114	52,402	154,145	154,151
Services [Member] | Revenues recognized in point in time [Member]
Disaggregation of Revenue [Line Items]
Total Revenues	11,157	10,743	32,531	31,880
Services [Member] | Revenues recognized over time [Member]
Disaggregation of Revenue [Line Items]
Total Revenues	$ 39,957	$ 41,659	$ 121,614	$ 122,271

Revenues (Schedule of Changes i

Revenues (Schedule of Changes in Deferred Revenue) (Details) - USD ($) $ in Thousands		Sep. 30, 2019	Dec. 31, 2018
Revenue Recognition [Abstract]
Deferred revenue	[1]	$ 68,956	$ 72,387
[1]	Includes $15.7 million and $18.4 million under long term deferred revenue in the Company's consolidated balance sheets as of September 30, 2019 and December 31, 2018, respectively.

Inventories (Details)

Inventories (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Inventory Disclosure [Abstract]
Finished goods	$ 87,046	$ 61,391
Work-in-process	3,388	2,616
Raw materials	74,308	59,517
Total Inventory	$ 164,742	$ 123,524

Goodwill and Other Intangible_3

Goodwill and Other Intangible Assets (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Sep. 30, 2019	Dec. 31, 2018	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Goodwill	$ 385,332	$ 385,849		$ 385,332
Amortization of intangible assets	$ 6,500		$ 8,000	$ 18,600	$ 24,200
Stratasys-Objet reporting unit [Member]
Percentage of fair value exceeding carrying value of reporting units		8.00%
Goodwill		$ 386,000
Expected cash flow period		5 years
Discount rate (as a percent)		14.00%
Growth rate (as a percent)		3.10%
Percentage of decrease in terminal year growth rate		1.00%
Percentage of increase in terminal year growth rate		1.00%
Change in fair value due to 1% decrease in terminal year growth rate		$ 48,000
Change in fair value due to 1% increase in terminal year growth rate		$ 80,000

Goodwill and Other Intangible_4

Goodwill and Other Intangible Assets (Schedule of Changes in the Carrying Amount of Goodwill) (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2019USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill as of January 1, 2019	$ 385,849
Foreign currency translation adjustments	(517)
Goodwill as of September 30, 2019	$ 385,332

Goodwill and Other Intangible_5

Goodwill and Other Intangible Assets (Schedule of Other Intangible Assets) (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 459,452	$ 457,963
Accumulated Amortization	(369,155)	(350,689)
Net Book Value	90,297	107,274
Developed technology [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	299,100	299,100
Accumulated Amortization	(248,197)	(236,375)
Net Book Value	50,903	62,725
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	11,739	10,127
Accumulated Amortization	(6,510)	(5,752)
Net Book Value	5,229	4,375
Trademarks and trade names [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	26,235	26,212
Accumulated Amortization	(19,933)	(19,067)
Net Book Value	6,302	7,145
Customer relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	102,837	102,984
Accumulated Amortization	(75,116)	(70,353)
Net Book Value	27,721	32,631
Capitalized software development costs [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	19,541	19,540
Accumulated Amortization	(19,399)	(19,142)
Net Book Value	$ 142	$ 398

Goodwill and Other Intangible_6

Goodwill and Other Intangible Assets (Schedule of Estimated Amortization Expense Relating to Intangible Assets) (Details) $ in Thousands	Sep. 30, 2019USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Remaining 3 months of 2019	$ 6,275
2020	24,278
2021	24,118
2022	24,022
Thereafter	11,604
Total	$ 90,297

Loss Per Share (Narrative) (Det

Loss Per Share (Narrative) (Details) - shares shares in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Earnings Per Share [Abstract]
Antidilutive securities excluded from computation of net loss per share	4.5	4.2	4.5	4.2

Loss Per Share (Schedule of Bas

Loss Per Share (Schedule of Basic and Diluted Loss Per Share) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Numerator:
Net loss attributable to Stratasys Ltd.	$ (6,941)	$ (679)	$ (8,059)	$ (17,271)
Adjustment of redeemable non-controlling interest to redemption amount				(935)
Net loss attributable to Stratasys Ltd. for basic and diluted loss per share	$ (6,941)	$ (679)	$ (8,059)	$ (18,206)
Denominator:
Weighted average shares - denominator for basic and diluted net loss per share	54,394	53,769	54,201	53,716
Net loss per share attributable to Stratasys Ltd.
Basic	$ (0.13)	$ (0.01)	$ (0.15)	$ (0.34)
Diluted	$ (0.13)	$ (0.01)	$ (0.15)	$ (0.34)

Income Taxes (Details)

Income Taxes (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Income Tax Disclosure [Abstract]
Effective Income Tax Rate, Continuing Operations	10.30%	9.20%	54.80%	21.50%

Fair Value Measurements (Schedu

Fair Value Measurements (Schedule of Fair Value Measurements) (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative asset (liabilities)	$ 1,229	$ (450)
Foreign Exchange Future [Member] | Recurring [Member] | Not Designated as Hedging Instrument [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets	857	374
Derivative liabilities	(184)	(196)
Foreign Exchange Future [Member] | Recurring [Member] | Designated as Hedging Instrument [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets	556
Derivative liabilities		$ (628)

Derivative instruments and he_3

Derivative instruments and hedging activities (Narrative) (Details) ₪ in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019USD ($)	Sep. 30, 2018USD ($)	Sep. 30, 2019USD ($)	Sep. 30, 2018USD ($)	Sep. 30, 2019ILS (₪)
Derivatives, Fair Value [Line Items]
Notional amount of derivative asset	$ 88.1		$ 88.1
Gain (Loss) on derivative instrument	$ 3.2	$ 0.6	$ 4.5	$ 1.5
Other current assets [Member] | Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member] | Conversion To NIS [Member]
Derivatives, Fair Value [Line Items]
Notional amount of derivative asset | ₪					₪ 17

Derivatives and Hedging Activit

Derivatives and Hedging Activities (Schedule of Balance Sheet Classification and Fair Values of Derivative Instruments) (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Derivatives, Fair Value [Line Items]
Notional amount of derivative asset	$ 88,100
Fair value	1,229	$ (450)
Notional amount	105,068	130,423
Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument [Member] | Other current assets [Member]
Derivatives, Fair Value [Line Items]
Fair value derivative asset	857	374
Notional amount of derivative asset	66,206	34,695
Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument [Member] | Accrued expenses and other current liabilities [Member]
Derivatives, Fair Value [Line Items]
Fair value derivative liability	(184)	(196)
Notional amount of derivative liability	21,907	54,425
Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member] | Other current assets [Member] | Cash Flow Hedge [Member]
Derivatives, Fair Value [Line Items]
Fair value derivative asset	556
Notional amount of derivative asset	16,955
Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member] | Accrued expenses and other current liabilities [Member] | Cash Flow Hedge [Member]
Derivatives, Fair Value [Line Items]
Fair value derivative liability		(628)
Notional amount of derivative liability		$ 41,303

Equity (Narrative) (Details)

Equity (Narrative) (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options exercised	242,317	87,158
Increase in equity	$ 5.2	$ 1.7
Unrecognized compensation cost	$ 5.1
Weighted average period for recognition	1 year 4 months 24 days
RSUs and PSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost	$ 45.1
Weighted average period for recognition	2 years 10 months 25 days

Equity (Schedule of Stock-based

Equity (Schedule of Stock-based Compensation) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expenses	$ 5,435	$ 4,013	$ 15,757	$ 11,706
Cost of sales [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expenses	475	351	1,370	1,180
Research and development, net [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expenses	1,494	928	3,764	2,608
Selling, general and administrative [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expenses	$ 3,466	$ 2,734	$ 10,623	$ 7,918

Equity (Schedule of Stock Optio

Equity (Schedule of Stock Option Activity) (Details) - $ / shares	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Number of Options
Options outstanding as of January 1, 2019	2,551,743
Exercised	(242,317)	(87,158)
Forfeited	(218,568)
Options outstanding as of September 30, 2019	2,090,858
Options exercisable as of September 30, 2019	1,600,304
Weighted Average Exercise Price
Options outstanding as of January 1, 2019	$ 30.82
Exercised	21.34
Forfeited	27.40
Options outstanding as of September 30, 2019	32.28
Options exercisable as of September 30, 2019	$ 35.90

Equity (Summary of RSUs and PSU

Equity (Summary of RSUs and PSUs Activity) (Details) - RSUs and PSUs [Member]	9 Months Ended
	Sep. 30, 2019$ / sharesshares
Number of RSUs and PSUs
Unvested as of January 1, 2019 | shares	1,422,887
Granted | shares	1,564,182
Vested | shares	(304,408)
Forfeited | shares	(251,574)
Unvested as of September 30, 2019 | shares	2,431,087
Weighted Average Grant Date Fair Value
Unvested as of January 1, 2019 | $ / shares	$ 20.17
Granted | $ / shares	26.61
Vested | $ / shares	20.47
Forfeited | $ / shares	22.19
Unvested as of September 30, 2019 | $ / shares	$ 24.07

Equity (Schedule of Accumulated

Equity (Schedule of Accumulated other comprehensive income (loss) (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance as of beginning of period	$ (7,753)	$ (7,023)
Other comprehensive income (loss) before reclassifications	291	(2,273)
Amounts reclassified from accumulated other comprehensive loss	(505)	481
Other comprehensive income (loss)	(214)	(1,792)
Balance as of end of period	(7,967)	(8,815)
Net unrealized gain (loss) on cash flow hedges [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance as of beginning of period	(627)	330
Other comprehensive income (loss) before reclassifications	1,689	(733)
Amounts reclassified from accumulated other comprehensive loss	(505)	386
Other comprehensive income (loss)	1,184	(347)
Balance as of end of period	557	(17)
Foreign currency translation adjustments [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance as of beginning of period	(7,126)	(7,353)
Other comprehensive income (loss) before reclassifications	(1,398)	(1,540)
Amounts reclassified from accumulated other comprehensive loss		95
Other comprehensive income (loss)	(1,398)	(1,445)
Balance as of end of period	$ (8,524)	$ (8,798)